{"entity":{"type":"insider","cik":"0001650274","url":"/insider/0001650274","json_url":"/insider/0001650274.json","name":"Smith David Ross","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":428,"n_filings":36,"first":"2017-03-07","last":"2022-03-04","span_basis":"filed_date"},"name_variants":[{"name":"Smith David Ross","source":"filing","n_filings":36,"first_seen":"2017-03-07","last_seen":"2022-03-04"}],"transactions":[{"id":6538579,"accession":"0001127602-22-008258","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001127602-22-008258","line_url":"/filing/0001127602-22-008258#line-8","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3825.0,"shares_display":"3,825","price_per_share":281.4944,"price_display":"281.49","price_state":"stated","total_value":1076716.08,"total_display":"1,076,716.08","shares_owned_after":30959.0,"shares_owned_after_display":"30,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-03","filed_date":"2022-03-04","scope":"insider"},{"id":6538577,"accession":"0001127602-22-008258","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001127602-22-008258","line_url":"/filing/0001127602-22-008258#line-7","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2606.0,"shares_display":"2,606","price_per_share":282.5636,"price_display":"282.56","price_state":"stated","total_value":736360.7416,"total_display":"736,360.74","shares_owned_after":28353.0,"shares_owned_after_display":"28,353","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-03","filed_date":"2022-03-04","scope":"insider"},{"id":6538573,"accession":"0001127602-22-008258","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001127602-22-008258","line_url":"/filing/0001127602-22-008258#line-6","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1289.0,"shares_display":"1,289","price_per_share":283.4106,"price_display":"283.41","price_state":"stated","total_value":365316.2634,"total_display":"365,316.26","shares_owned_after":27064.0,"shares_owned_after_display":"27,064","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-03","filed_date":"2022-03-04","scope":"insider"},{"id":6538568,"accession":"0001127602-22-008258","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001127602-22-008258","line_url":"/filing/0001127602-22-008258#line-5","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":858.0,"shares_display":"858","price_per_share":284.5814,"price_display":"284.58","price_state":"stated","total_value":244170.8412,"total_display":"244,170.84","shares_owned_after":26206.0,"shares_owned_after_display":"26,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-03","filed_date":"2022-03-04","scope":"insider"},{"id":6538565,"accession":"0001127602-22-008258","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-22-008258","line_url":"/filing/0001127602-22-008258#line-4","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":387.0,"shares_display":"387","price_per_share":285.1593,"price_display":"285.16","price_state":"stated","total_value":110356.6491,"total_display":"110,356.65","shares_owned_after":25819.0,"shares_owned_after_display":"25,819","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-03","filed_date":"2022-03-04","scope":"insider"},{"id":4961454,"accession":"0001127602-21-023436","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-023436","line_url":"/filing/0001127602-21-023436#line-2","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1150.0,"shares_display":"1,150","price_per_share":407.9471,"price_display":"407.95","price_state":"stated","total_value":469139.165,"total_display":"469,139.16","shares_owned_after":14425.0,"shares_owned_after_display":"14,425","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-09","filed_date":"2021-08-10","scope":"insider"},{"id":4961448,"accession":"0001127602-21-023436","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-023436","line_url":"/filing/0001127602-21-023436#line-1","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":406.3584,"price_display":"406.36","price_state":"stated","total_value":243815.04,"total_display":"243,815.04","shares_owned_after":15575.0,"shares_owned_after_display":"15,575","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-09","filed_date":"2021-08-10","scope":"insider"},{"id":5060198,"accession":"0001127602-21-015655","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-015655","line_url":"/filing/0001127602-21-015655#line-2","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3305.0,"shares_display":"3,305","price_per_share":340.0055,"price_display":"340.01","price_state":"stated","total_value":1123718.1775,"total_display":"1,123,718.18","shares_owned_after":14862.0,"shares_owned_after_display":"14,862","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-04","filed_date":"2021-05-06","scope":"insider"},{"id":4886556,"accession":"0001127602-21-014394","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-014394","line_url":"/filing/0001127602-21-014394#line-2","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3845.0,"shares_display":"3,845","price_per_share":330.0,"price_display":"330.00","price_state":"stated","total_value":1268850.0,"total_display":"1,268,850.00","shares_owned_after":14862.0,"shares_owned_after_display":"14,862","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-22","filed_date":"2021-04-26","scope":"insider"},{"id":5468083,"accession":"0001127602-21-013835","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-013835","line_url":"/filing/0001127602-21-013835#line-1","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":320.0,"price_display":"320.00","price_state":"stated","total_value":640000.0,"total_display":"640,000.00","shares_owned_after":14862.0,"shares_owned_after_display":"14,862","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-15","filed_date":"2021-04-16","scope":"insider"},{"id":5107895,"accession":"0001127602-21-008729","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-008729","line_url":"/filing/0001127602-21-008729#line-2","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4366.0,"shares_display":"4,366","price_per_share":290.1161,"price_display":"290.12","price_state":"stated","total_value":1266646.8926,"total_display":"1,266,646.89","shares_owned_after":16862.0,"shares_owned_after_display":"16,862","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-02","scope":"insider"},{"id":5107756,"accession":"0001127602-21-007205","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-21-007205","line_url":"/filing/0001127602-21-007205#line-3","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6107.0,"shares_display":"6,107","price_per_share":290.0263,"price_display":"290.03","price_state":"stated","total_value":1771190.6141,"total_display":"1,771,190.61","shares_owned_after":2549.0,"shares_owned_after_display":"2,549","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-19","filed_date":"2021-02-23","scope":"insider"},{"id":5107752,"accession":"0001127602-21-007205","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-007205","line_url":"/filing/0001127602-21-007205#line-2","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":291.8271,"price_display":"291.83","price_state":"stated","total_value":408557.94,"total_display":"408,557.94","shares_owned_after":1149.0,"shares_owned_after_display":"1,149","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-19","filed_date":"2021-02-23","scope":"insider"},{"id":5107749,"accession":"0001127602-21-007205","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-007205","line_url":"/filing/0001127602-21-007205#line-1","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1149.0,"shares_display":"1,149","price_per_share":292.3735,"price_display":"292.37","price_state":"stated","total_value":335937.1515,"total_display":"335,937.15","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-19","filed_date":"2021-02-23","scope":"insider"},{"id":5207569,"accession":"0001127602-21-000746","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001127602-21-000746","line_url":"/filing/0001127602-21-000746#line-12","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":935.0,"shares_display":"935","price_per_share":248.8359,"price_display":"248.84","price_state":"stated","total_value":232661.5665,"total_display":"232,661.57","shares_owned_after":17581.0,"shares_owned_after_display":"17,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-05","scope":"insider"},{"id":5207566,"accession":"0001127602-21-000746","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001127602-21-000746","line_url":"/filing/0001127602-21-000746#line-11","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":756.0,"shares_display":"756","price_per_share":247.8921,"price_display":"247.89","price_state":"stated","total_value":187406.4276,"total_display":"187,406.43","shares_owned_after":18516.0,"shares_owned_after_display":"18,516","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-05","scope":"insider"},{"id":5207561,"accession":"0001127602-21-000746","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001127602-21-000746","line_url":"/filing/0001127602-21-000746#line-10","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":535.0,"shares_display":"535","price_per_share":246.7615,"price_display":"246.76","price_state":"stated","total_value":132017.4025,"total_display":"132,017.40","shares_owned_after":19272.0,"shares_owned_after_display":"19,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-05","scope":"insider"},{"id":5207557,"accession":"0001127602-21-000746","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001127602-21-000746","line_url":"/filing/0001127602-21-000746#line-9","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":531.0,"shares_display":"531","price_per_share":249.9702,"price_display":"249.97","price_state":"stated","total_value":132734.1762,"total_display":"132,734.18","shares_owned_after":17050.0,"shares_owned_after_display":"17,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-05","scope":"insider"},{"id":5207554,"accession":"0001127602-21-000746","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001127602-21-000746","line_url":"/filing/0001127602-21-000746#line-8","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":531.0,"shares_display":"531","price_per_share":243.7054,"price_display":"243.71","price_state":"stated","total_value":129407.5674,"total_display":"129,407.57","shares_owned_after":20236.0,"shares_owned_after_display":"20,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-05","scope":"insider"},{"id":5207550,"accession":"0001127602-21-000746","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001127602-21-000746","line_url":"/filing/0001127602-21-000746#line-7","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":426.0,"shares_display":"426","price_per_share":251.9031,"price_display":"251.90","price_state":"stated","total_value":107310.7206,"total_display":"107,310.72","shares_owned_after":16491.0,"shares_owned_after_display":"16,491","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-05","scope":"insider"},{"id":5207543,"accession":"0001127602-21-000746","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001127602-21-000746","line_url":"/filing/0001127602-21-000746#line-6","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":310.0,"shares_display":"310","price_per_share":253.8827,"price_display":"253.88","price_state":"stated","total_value":78703.637,"total_display":"78,703.64","shares_owned_after":15878.0,"shares_owned_after_display":"15,878","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-05","scope":"insider"},{"id":5207532,"accession":"0001127602-21-000746","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001127602-21-000746","line_url":"/filing/0001127602-21-000746#line-5","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":303.0,"shares_display":"303","price_per_share":252.9906,"price_display":"252.99","price_state":"stated","total_value":76656.1518,"total_display":"76,656.15","shares_owned_after":16188.0,"shares_owned_after_display":"16,188","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-05","scope":"insider"},{"id":5207530,"accession":"0001127602-21-000746","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-21-000746","line_url":"/filing/0001127602-21-000746#line-4","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":264.0,"shares_display":"264","price_per_share":245.5689,"price_display":"245.57","price_state":"stated","total_value":64830.1896,"total_display":"64,830.19","shares_owned_after":19807.0,"shares_owned_after_display":"19,807","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-05","scope":"insider"},{"id":5207525,"accession":"0001127602-21-000746","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-21-000746","line_url":"/filing/0001127602-21-000746#line-3","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":165.0,"shares_display":"165","price_per_share":244.9429,"price_display":"244.94","price_state":"stated","total_value":40415.5785,"total_display":"40,415.58","shares_owned_after":20071.0,"shares_owned_after_display":"20,071","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-05","scope":"insider"},{"id":5207519,"accession":"0001127602-21-000746","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-000746","line_url":"/filing/0001127602-21-000746#line-2","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":133.0,"shares_display":"133","price_per_share":250.8663,"price_display":"250.87","price_state":"stated","total_value":33365.2179,"total_display":"33,365.22","shares_owned_after":16917.0,"shares_owned_after_display":"16,917","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-05","scope":"insider"},{"id":5207507,"accession":"0001127602-21-000746","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-000746","line_url":"/filing/0001127602-21-000746#line-1","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":111.0,"shares_display":"111","price_per_share":254.7728,"price_display":"254.77","price_state":"stated","total_value":28279.7808,"total_display":"28,279.78","shares_owned_after":15767.0,"shares_owned_after_display":"15,767","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-05","scope":"insider"},{"id":2176547,"accession":"0001127602-20-023248","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-20-023248","line_url":"/filing/0001127602-20-023248#line-3","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2297.0,"shares_display":"2,297","price_per_share":216.4169,"price_display":"216.42","price_state":"stated","total_value":497109.6193,"total_display":"497,109.62","shares_owned_after":21774.0,"shares_owned_after_display":"21,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-07","filed_date":"2020-08-10","scope":"insider"},{"id":2176544,"accession":"0001127602-20-023248","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-20-023248","line_url":"/filing/0001127602-20-023248#line-2","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1007.0,"shares_display":"1,007","price_per_share":216.8165,"price_display":"216.82","price_state":"stated","total_value":218334.2155,"total_display":"218,334.22","shares_owned_after":20767.0,"shares_owned_after_display":"20,767","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-07","filed_date":"2020-08-10","scope":"insider"},{"id":2215652,"accession":"0001127602-20-015882","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-015882","line_url":"/filing/0001127602-20-015882#line-1","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1884.0,"shares_display":"1,884","price_per_share":150.0,"price_display":"150.00","price_state":"stated","total_value":282600.0,"total_display":"282,600.00","shares_owned_after":18591.0,"shares_owned_after_display":"18,591","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-07","filed_date":"2020-05-08","scope":"insider"},{"id":3005002,"accession":"0001127602-20-008104","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001127602-20-008104","line_url":"/filing/0001127602-20-008104#line-6","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1027.0,"shares_display":"1,027","price_per_share":162.2722,"price_display":"162.27","price_state":"stated","total_value":166653.5494,"total_display":"166,653.55","shares_owned_after":21870.0,"shares_owned_after_display":"21,870","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-26","filed_date":"2020-02-27","scope":"insider"},{"id":3004998,"accession":"0001127602-20-008104","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001127602-20-008104","line_url":"/filing/0001127602-20-008104#line-5","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":898.0,"shares_display":"898","price_per_share":161.5755,"price_display":"161.58","price_state":"stated","total_value":145094.799,"total_display":"145,094.80","shares_owned_after":22897.0,"shares_owned_after_display":"22,897","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-26","filed_date":"2020-02-27","scope":"insider"},{"id":3004994,"accession":"0001127602-20-008104","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-20-008104","line_url":"/filing/0001127602-20-008104#line-4","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":868.0,"shares_display":"868","price_per_share":160.4509,"price_display":"160.45","price_state":"stated","total_value":139271.3812,"total_display":"139,271.38","shares_owned_after":23795.0,"shares_owned_after_display":"23,795","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-26","filed_date":"2020-02-27","scope":"insider"},{"id":3004990,"accession":"0001127602-20-008104","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-20-008104","line_url":"/filing/0001127602-20-008104#line-3","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":738.0,"shares_display":"738","price_per_share":164.1948,"price_display":"164.19","price_state":"stated","total_value":121175.7624,"total_display":"121,175.76","shares_owned_after":20475.0,"shares_owned_after_display":"20,475","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-26","filed_date":"2020-02-27","scope":"insider"},{"id":3004984,"accession":"0001127602-20-008104","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-20-008104","line_url":"/filing/0001127602-20-008104#line-2","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":657.0,"shares_display":"657","price_per_share":163.378,"price_display":"163.38","price_state":"stated","total_value":107339.346,"total_display":"107,339.35","shares_owned_after":21213.0,"shares_owned_after_display":"21,213","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-26","filed_date":"2020-02-27","scope":"insider"},{"id":3288891,"accession":"0001127602-20-007487","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001127602-20-007487","line_url":"/filing/0001127602-20-007487#line-5","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6875.0,"shares_display":"6,875","price_per_share":166.5271,"price_display":"166.53","price_state":"stated","total_value":1144873.8125,"total_display":"1,144,873.81","shares_owned_after":22190.0,"shares_owned_after_display":"22,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-24","filed_date":"2020-02-25","scope":"insider"},{"id":3288889,"accession":"0001127602-20-007487","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-20-007487","line_url":"/filing/0001127602-20-007487#line-4","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":985.0,"shares_display":"985","price_per_share":167.4942,"price_display":"167.49","price_state":"stated","total_value":164981.787,"total_display":"164,981.79","shares_owned_after":21205.0,"shares_owned_after_display":"21,205","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-24","filed_date":"2020-02-25","scope":"insider"},{"id":3288886,"accession":"0001127602-20-007487","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-20-007487","line_url":"/filing/0001127602-20-007487#line-3","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":351.0,"shares_display":"351","price_per_share":168.3681,"price_display":"168.37","price_state":"stated","total_value":59097.2031,"total_display":"59,097.20","shares_owned_after":20854.0,"shares_owned_after_display":"20,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-24","filed_date":"2020-02-25","scope":"insider"},{"id":3004506,"accession":"0001127602-20-005367","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-005367","line_url":"/filing/0001127602-20-005367#line-1","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":170.293,"price_display":"170.29","price_state":"stated","total_value":766318.5,"total_display":"766,318.50","shares_owned_after":21978.0,"shares_owned_after_display":"21,978","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-13","filed_date":"2020-02-13","scope":"insider"},{"id":8037104,"accession":"0001127602-19-026518","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001127602-19-026518","line_url":"/filing/0001127602-19-026518#line-21","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":208.0,"shares_display":"208","price_per_share":131.19,"price_display":"131.19","price_state":"stated","total_value":27287.52,"total_display":"27,287.52","shares_owned_after":18085.0,"shares_owned_after_display":"18,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-12","filed_date":"2019-08-13","scope":"insider"},{"id":8037101,"accession":"0001127602-19-026518","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001127602-19-026518","line_url":"/filing/0001127602-19-026518#line-20","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":123.0,"shares_display":"123","price_per_share":129.67,"price_display":"129.67","price_state":"stated","total_value":15949.41,"total_display":"15,949.41","shares_owned_after":18990.0,"shares_owned_after_display":"18,990","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-12","filed_date":"2019-08-13","scope":"insider"},{"id":8037098,"accession":"0001127602-19-026518","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001127602-19-026518","line_url":"/filing/0001127602-19-026518#line-19","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":119.0,"shares_display":"119","price_per_share":129.04,"price_display":"129.04","price_state":"stated","total_value":15355.76,"total_display":"15,355.76","shares_owned_after":19113.0,"shares_owned_after_display":"19,113","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-12","filed_date":"2019-08-13","scope":"insider"},{"id":8037094,"accession":"0001127602-19-026518","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001127602-19-026518","line_url":"/filing/0001127602-19-026518#line-18","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":116.0,"shares_display":"116","price_per_share":130.51,"price_display":"130.51","price_state":"stated","total_value":15139.16,"total_display":"15,139.16","shares_owned_after":18651.0,"shares_owned_after_display":"18,651","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-12","filed_date":"2019-08-13","scope":"insider"},{"id":8037091,"accession":"0001127602-19-026518","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001127602-19-026518","line_url":"/filing/0001127602-19-026518#line-17","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":114.0,"shares_display":"114","price_per_share":130.32,"price_display":"130.32","price_state":"stated","total_value":14856.48,"total_display":"14,856.48","shares_owned_after":18876.0,"shares_owned_after_display":"18,876","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-12","filed_date":"2019-08-13","scope":"insider"},{"id":8037088,"accession":"0001127602-19-026518","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001127602-19-026518","line_url":"/filing/0001127602-19-026518#line-16","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":109.0,"shares_display":"109","price_per_share":130.44,"price_display":"130.44","price_state":"stated","total_value":14217.96,"total_display":"14,217.96","shares_owned_after":18767.0,"shares_owned_after_display":"18,767","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-12","filed_date":"2019-08-13","scope":"insider"},{"id":8037082,"accession":"0001127602-19-026518","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001127602-19-026518","line_url":"/filing/0001127602-19-026518#line-15","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":107.0,"shares_display":"107","price_per_share":130.91,"price_display":"130.91","price_state":"stated","total_value":14007.37,"total_display":"14,007.37","shares_owned_after":18418.0,"shares_owned_after_display":"18,418","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-12","filed_date":"2019-08-13","scope":"insider"},{"id":8037079,"accession":"0001127602-19-026518","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001127602-19-026518","line_url":"/filing/0001127602-19-026518#line-14","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":105.0,"shares_display":"105","price_per_share":130.64,"price_display":"130.64","price_state":"stated","total_value":13717.2,"total_display":"13,717.20","shares_owned_after":18546.0,"shares_owned_after_display":"18,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-12","filed_date":"2019-08-13","scope":"insider"},{"id":8037076,"accession":"0001127602-19-026518","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001127602-19-026518","line_url":"/filing/0001127602-19-026518#line-13","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":101.0,"shares_display":"101","price_per_share":131.08,"price_display":"131.08","price_state":"stated","total_value":13239.08,"total_display":"13,239.08","shares_owned_after":18297.0,"shares_owned_after_display":"18,297","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-12","filed_date":"2019-08-13","scope":"insider"},{"id":8037074,"accession":"0001127602-19-026518","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001127602-19-026518","line_url":"/filing/0001127602-19-026518#line-12","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":95.0,"shares_display":"95","price_per_share":128.85,"price_display":"128.85","price_state":"stated","total_value":12240.75,"total_display":"12,240.75","shares_owned_after":19232.0,"shares_owned_after_display":"19,232","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-12","filed_date":"2019-08-13","scope":"insider"},{"id":8037070,"accession":"0001127602-19-026518","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001127602-19-026518","line_url":"/filing/0001127602-19-026518#line-11","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9.0,"shares_display":"9","price_per_share":130.79,"price_display":"130.79","price_state":"stated","total_value":1177.11,"total_display":"1,177.11","shares_owned_after":18537.0,"shares_owned_after_display":"18,537","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-12","filed_date":"2019-08-13","scope":"insider"},{"id":8037063,"accession":"0001127602-19-026518","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001127602-19-026518","line_url":"/filing/0001127602-19-026518#line-10","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001650274","owner_name":"Smith David Ross","owner_url":"/insider/0001650274","role":"Officer (Corporate Executive VP & CFO)","officer_title":"Corporate Executive VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8.0,"shares_display":"8","price_per_share":131.0,"price_display":"131.00","price_state":"stated","total_value":1048.0,"total_display":"1,048.00","shares_owned_after":18406.0,"shares_owned_after_display":"18,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-12","filed_date":"2019-08-13","scope":"insider"}],"next_cursor":"2019-08-12|8037063","ledger_fault":false,"count":{"value":428,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":428,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":428},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001100682","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","url":"/issuer/0001100682","role":"Officer (Corporate Executive VP & CFO)","n_filings":36,"first_seen":"2017-03-07","last_seen":"2022-03-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001650274","retrieved_at":"2026-08-20T18:56:07+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}